DRAFT AGENDA
PEDIATRIC ADVISORY SUBCOMMITTEE MEETING
CURRENT EPIDEMIOLOGY AND
THERAPEUTIC INTERVENTIONS RELEVANT TO HYPERBILIRUBINEMIA IN THE TERM AND
NEAR-TERM NEWBORN
Day #1 –
Director,
Office of Pediatric Therapeutics
Joseph Lau, M.D.
Rebecca O’Brien, M.D.
Parents
of Infants and Children
with Kernicterus
Centers
for Disease Control and Prevention
The
Children’s